Favipiravir tablets and preparation method thereof
The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellu...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to favipiravir tablets. The tablets comprise favipiravir, silicified microcrystalline cellulose and adhesive; the silicified microcrystalline cellulose is lower in price, proper in size and high in medicine compliance when being compared with low-substituted hydroxypropyl cellulose; the defective rate is lower and the dissolution rate is higher. The invention further relates to a preparation method of the tablets. The preparation method is simple in preparation process and suitable for industrialized large-scale production.
本发明涉及种法匹拉韦片剂,该片剂含有法匹拉韦、硅化微晶纤维素和粘合剂,采用硅化微晶纤维素相对于低取代羟丙基纤维素,价格更加低廉、大小合适、药物顺应性良好,并且次品率更低和溶出更好。本发明还涉及所述片剂的制备方法,该制备方法制备工艺简单,适合工业化大生产。 |
---|